Anti-Viral Therapies Market

1
Anti-Viral Therapies Market 
Anti-Viral Therapies Market Forecast to 2027 -
COVID-19 Impact and Global Analysis by Type
(Generic Drugs, Branded Drugs) Mechanism of
Action (Nucleotide Polymerase Inhibitor, Reverse
Transcriptase Inhibitors, Protease Inhibitors,
Others) Application (HIV, Hepatitis, Virus
Influenza, Herpes, Other Applications) and
Geography
2
Current and future Market Scenario
Anti-Viral Therapies Market 

• According to our new market research study on
  Anti-Viral Therapies Market to 2027 Global
  Analysis and Forecast by Type, Mechanism of
  Action and Application, the market is expected
  to reach US 76,282.63 million by 2027 from US
  40,589.79 million in 2019.

3
Market Segments
Anti-Viral Therapies Market   
By Type Generic Drugs Branded Drugs
By Mechanism of Action Nucleotide Polymerase
Inhibitor Reverse Transcriptase
Inhibitors Protease Inhibitors Others
By Application HIV Hepatitis Virus
Influenza Herpes Other Applications
4
Leading Players
Anti-Viral Therapies Market  
Company Profiles in Anti-Viral Therapies Market
are AbbVie Inc. Abbott F. Hoffmann-La Roche
Ltd Bristol-Myers Squibb Company Johnson
Johnson Services, Inc. Merck and Co., Inc. Gilead
Sciences, Inc. GlaxoSmithKline plc Aurobindo
Pharma AstraZeneca
5
Anti-Viral Therapies Market  
Access Full Research Report at
https//www.theinsightpartners.com/reports/anti-vi
ral-therapies-market
Thank You!

• Thank You!